Literature DB >> 12517882

Identification of Candida spp. by randomly amplified polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods.

Consuelo Bautista-Muñoz1, Xavier M Boldo, Lourdes Villa-Tanaca, César Hernández-Rodríguez.   

Abstract

Because Candida species have innately highly variable antifungal susceptibilities, the availability of a fast and reliable species identification test is very important so that suitable and effective therapeutic measures may be taken. Using three oligonucleotide primers, we established a randomly amplified polymorphic DNA (RAPD) analysis method that enabled direct identification of the most common opportunistic pathogenic Candida species. RAPD analysis revealed a characteristic molecular fingerprint for each Candida species. Differences between the profiles for Candida albicans and C. dubliniensis were evident. RAPD analysis is a relatively easy, reproducible, and reliable technique that can be useful in providing genetic fingerprints for the identification of strains. In addition, a collection of different C. albicans strains was identified by a specific PCR based on multiple secreted aspartic proteinase (SAP) genes and the dipeptidyl aminopeptidase (DAP2) gene. Our findings demonstrate that PCR based upon the SAP and DAP2 sequences is a simple, rapid, clear, and direct technique for the identification and differentiation of C. albicans and C. dubliniensis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517882      PMCID: PMC149553          DOI: 10.1128/JCM.41.1.414-420.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  35 in total

1.  PCR-based identification of pathogenic Candida species using primer mixes specific to Candida DNA topoisomerase II genes.

Authors:  Toshio Kanbe; Toshinobu Horii; Takuo Arishima; Munetaka Ozeki; Akihiko Kikuchi
Journal:  Yeast       Date:  2002-08       Impact factor: 3.239

2.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

3.  Rapid identification of Candida species with species-specific DNA probes.

Authors:  C M Elie; T J Lott; E Reiss; C J Morrison
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

4.  Rapid detection and identification of Candida albicans and Torulopsis (Candida) glabrata in clinical specimens by species-specific nested PCR amplification of a cytochrome P-450 lanosterol-alpha-demethylase (L1A1) gene fragment.

Authors:  P Burgener-Kairuz; J P Zuber; P Jaunin; T G Buchman; J Bille; M Rossier
Journal:  J Clin Microbiol       Date:  1994-08       Impact factor: 5.948

5.  Comparison of four DNA-based methods for strain delineation of Candida lusitaniae.

Authors:  D King; J Rhine-Chalberg; M A Pfaller; S A Moser; W G Merz
Journal:  J Clin Microbiol       Date:  1995-06       Impact factor: 5.948

6.  Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood.

Authors:  S Fujita; B A Lasker; T J Lott; E Reiss; C J Morrison
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

7.  PCR identification of four medically important Candida species by using a single primer pair.

Authors:  J A Jordan
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

8.  Misidentification of clinical yeast isolates by using the updated Vitek Yeast Biochemical Card.

Authors:  D P Dooley; M L Beckius; B S Jeffrey
Journal:  J Clin Microbiol       Date:  1994-12       Impact factor: 5.948

9.  Phenotypic and genotypic characterization of unusual vaginal isolates of Candida albicans from Africa.

Authors:  H J Tietz; A Küssner; M Thanos; M P De Andrade; W Presber; G Schönian
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

10.  Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA.

Authors:  D W Williams; M J Wilson; M A Lewis; A J Potts
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

View more
  13 in total

1.  Genetic diversity among clinical isolates of Candida glabrata analyzed by randomly amplified polymorphic DNA and multilocus enzyme electrophoresis analyses.

Authors:  Xavier M Boldo; Lourdes Villa-Tanaca; Gerardo Zúñiga; César Hernández-Rodríguez
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

2.  Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United kingdom mycology reference laboratory.

Authors:  Christopher J Linton; Andrew M Borman; Grace Cheung; Ann D Holmes; Adrien Szekely; Michael D Palmer; Paul D Bridge; Colin K Campbell; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2007-01-24       Impact factor: 5.948

3.  Candida nivariensis isolated from an Indonesian human immunodeficiency virus-infected patient suffering from oropharyngeal candidiasis.

Authors:  Retno Wahyuningsih; Ivo N SahBandar; Bart Theelen; Ferry Hagen; Gé Poot; Jacques F Meis; Anna Rozalyani; Ridhawati Sjam; Djoko Widodo; Samsuridjal Djauzi; Teun Boekhout
Journal:  J Clin Microbiol       Date:  2007-11-14       Impact factor: 5.948

4.  Rapid emergence of echinocandin resistance in Candida glabrata resulting in clinical and microbiologic failure.

Authors:  James S Lewis; Nathan P Wiederhold; Brian L Wickes; Thomas F Patterson; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

5.  Detection of Candida dubliniensis in Venezuela.

Authors:  Claudia Hartung de Capriles; Sofía Mata-Essayag; Celina Pérez; Maria Teresa Colella; Arantza Roselló; Carolina Olaizola; Sylvia Magaldi Teresa Abate
Journal:  Mycopathologia       Date:  2005-10       Impact factor: 2.574

6.  In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei.

Authors:  Elisabete Ricardo; Isabel M Miranda; Isabel Faria-Ramos; Raquel M Silva; Acácio Gonçalves Rodrigues; Cidália Pina-Vaz
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

7.  Candida species lens abscesses in infants with a history of neonatal Candida sepsis.

Authors:  Natario L Couser; G Baker Hubbard; Lyndon B Lee; Amy K Hutchinson; Scott R Lambert
Journal:  J AAPOS       Date:  2013-04       Impact factor: 1.220

8.  Loss of in vitro resistance in Candida glabrata following discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patient.

Authors:  Steven D Westbrook; Nathan P Wiederhold; Ana C Vallor; Susann Kotara; Stella Bernardo; Samuel A Lee; William R Kirkpatrick; Juan J Toro; Cesaro Freytes; Thomas F Patterson; Spencer W Redding
Journal:  Med Mycol       Date:  2010-05       Impact factor: 4.076

9.  FKS2 mutations associated with decreased echinocandin susceptibility of Candida glabrata following anidulafungin therapy.

Authors:  Sofia Costa-de-Oliveira; Isabel Marcos Miranda; Raquel M Silva; Ana Pinto E Silva; Rita Rocha; António Amorim; Acácio Gonçalves Rodrigues; Cidália Pina-Vaz
Journal:  Antimicrob Agents Chemother       Date:  2010-12-13       Impact factor: 5.191

10.  Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.

Authors:  George R Thompson; Nathan P Wiederhold; Ana C Vallor; Nyria C Villareal; James S Lewis; Thomas F Patterson
Journal:  Antimicrob Agents Chemother       Date:  2008-08-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.